India to Dominican Republic: Bevacizumab Export Trade Route
India has recorded 13 verified shipments of Bevacizumab exported to Dominican Republic, representing a combined trade value of $372.2K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $28.6K USD. The leading Indian exporter is RELIANCE LIFE SCIENCES PRIVATE LIMITED, which accounts for 73% of total export value with 10 shipments worth $270.0K USD. On the buying side, SEAN DOMINICAN SRL is the largest importer in Dominican Republic with $357.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Dominican Republic Bevacizumab corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $372.2K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $28.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #5 among India's top bevacizumab export destinations globally.
On the import side, key buyers of Indian bevacizumab in Dominican Republic include SEAN DOMINICAN SRL, Sean Dominican Srl. SEAN DOMINICAN SRL is the single largest importer with 11 shipments valued at $357.9K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#5
- Annual growth+26.8%
- Demand growth+24.4%
- Regulatory ease83/100
Top 10 Indian Bevacizumab Exporters to Dominican Republic
Showing top 10 of 2 Indian suppliers exporting Bevacizumab to Dominican Republic, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $27.0K per shipment | 10 | $270.0K | 72.6% |
| 2 | RELIANCE LIFE SCIENCES PVT LTD Avg $34.0K per shipment | 3 | $102.1K | 27.4% |
This table shows the top 10 of 2 Indian companies exporting bevacizumab to Dominican Republic, ranked by total trade value. The listed exporters are: RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PVT LTD. RELIANCE LIFE SCIENCES PRIVATE LIMITED is the dominant supplier with 10 shipments worth $270.0K USD, giving it a 73% market share.
Top 10 Bevacizumab Importers in Dominican Republic
Showing top 10 of 2 known buyers in Dominican Republic receiving Bevacizumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bevacizumab in Dominican Republic include SEAN DOMINICAN SRL, Sean Dominican Srl. The largest importer is SEAN DOMINICAN SRL, accounting for $357.9K USD across 11 shipments — representing 96% of all bevacizumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SEAN DOMINICAN SRL | 11 | $357.9K | 96.2% |
| 2 | Sean Dominican Srl | 2 | $14.3K | 3.8% |
Top 10 Bevacizumab Formulations Imported by Dominican Republic
Showing top 10 of 10 product formulations shipped on the India to Dominican Republic Bevacizumab route, ranked by trade value
Dominican Republic imports a wide range of bevacizumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BEVACIZUMAB INJECTION 400MG/16ML (BEVACIREL 400MG) — accounts for $156.2K USD across 2 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BEVACIZUMAB INJECTION 400MG/16ML (BEVACIREL 400MG) | 2 | $156.2K | 42.0% |
| 2 | BEVACIZUMAB 400MGBEVACIREL 400MG | 1 | $88.9K | 23.9% |
| 3 | BEVACIZUMAB INJECTION 400MG/16ML BEVACIREL 400MG | 1 | $49.1K | 13.2% |
| 4 | BEVACIZUMAB INJECTION 100MG/4ML (BEVACIREL 100MG) | 2 | $41.7K | 11.2% |
| 5 | BEVACIZUMAB 100MG BEVACIREL 100MG | 2 | $13.1K | 3.5% |
| 6 | BEVACIZUMAB 400MG BEVACIREL 400MG | 1 | $9.9K | 2.7% |
| 7 | BEVACIZUMAB INJECTION 100MG/4ML BEVACIREL 100MG | 1 | $8.8K | 2.4% |
| 8 | BEVACIZUMAB 100MGBEVACIREL 100MG | 1 | $4.5K | 1.2% |
| 9 | BEVACIZUMAB INJECTION 400MG/16ML (BEVACIREL 400MG)(DELIVERY CHALLAN NO.271550000002894 ARN NO.AD270224026110T VALID UPTO | 1 | $0 | 0.0% |
| 10 | BEVACIZUMAB INJECTION 100MG/4ML (BEVACIREL 100MG) DELIVERY CHALLAN NO.27155000002895 DT.11.03.2025 IGST VIDE ARN NO.AD27 | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 4 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's bevacizumab exports to Dominican Republic are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Dominican Republic benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PVT LTD — together account for 100% of total trade value on this route. The average shipment value of $28.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as bevacizumab 400mgbevacirel 400mg and bevacizumab injection 400mg/16ml bevacirel 400mg, suggesting that buyers in Dominican Republic tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SEAN DOMINICAN SRL is the largest importer with 11 shipments worth $357.9K USD — representing 96% of all bevacizumab imports from India on this route.
Route Statistics
- Trade Volume
- $372.2K
- Avg. Shipment
- $28.6K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~24 days
- Annual Growth
- +26.8%
Related Analysis
Other Bevacizumab Routes
Unlock the Full India to Dominican Republic Bevacizumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 13 shipments on this route.
Frequently Asked Questions — India to Dominican Republic Bevacizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bevacizumab to Dominican Republic?
The leading Indian exporters of Bevacizumab to Dominican Republic are RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PVT LTD. RELIANCE LIFE SCIENCES PRIVATE LIMITED holds the largest market share at approximately 73% of total trade value on this route.
Q What is the total value of Bevacizumab exports from India to Dominican Republic?
India exports Bevacizumab to Dominican Republic worth approximately $372.2K USD across 13 recorded shipments. The average value per shipment is $28.6K USD.
Q Which ports does India use to ship Bevacizumab to Dominican Republic?
The most active port of origin is SAHAR AIR with 4 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Dominican Republic for Bevacizumab?
The average transit time for Bevacizumab shipments from India to Dominican Republic is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Dominican Republic Bevacizumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.8% with demand growth tracking at 24.4%. The route is ranked #5 among India's top Bevacizumab export destinations globally.
Q How many suppliers are active on the India to Dominican Republic Bevacizumab route?
There are currently 2 active Indian suppliers exporting Bevacizumab to Dominican Republic. The market is moderately concentrated with RELIANCE LIFE SCIENCES PRIVATE LIMITED accounting for 73% of total shipment value.
Q Who are the main importers of Bevacizumab from India in Dominican Republic?
The leading importers of Indian Bevacizumab in Dominican Republic include SEAN DOMINICAN SRL, Sean Dominican Srl. SEAN DOMINICAN SRL is the largest buyer with 11 shipments worth $357.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Dominican Republic export trade corridor identified from Indian Customs (DGFT) records for Bevacizumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Dominican Republic matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 13 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists